HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dai-hong Liu Selected Research

Hematologic Diseases (Blood Diseases)

12/2013[The efficacy and safety of modified busulfan/fludarabine conditioning regimen in elderly or drug-intolerable patients with hematologic malignancies].
3/2013[The value of the current diagnostic criteria of pulmonary invasive fungal infection after allogeneic hematopoietic stem cell transplantation].
10/2009[Secondary prophylaxis of invasive fungal infection in haematopoietic stem cell recipients].
8/2006[A comparative study of peripheral blood stem cell vs bone marrow transplantation from unrelated donors].
11/2005[Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
11/2005[Analysis of 66 cases received hematopoietic stem cell transplantation from unrelated donors].
6/2005[Efficacy of intravenous administration of itraconazole on fungal infections in immunocompromised patients with hematological diseases].
5/2005[Reduced intensity of BuCy conditioning regimen for transplantation in the treatment of malignant hematologic diseases].
12/2004A novel approach to human leukocyte antigen-mismatched transplantation in patients with malignant hematological disease.
8/2004[Mismatched hematopoietic stem cell transplantation using GIAC protocol: report of 100 cases].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dai-hong Liu Research Topics

Disease

17Graft vs Host Disease (Graft-Versus-Host Disease)
07/2015 - 06/2004
10Leukemia
07/2015 - 11/2005
10Hematologic Diseases (Blood Diseases)
12/2013 - 08/2004
7Infections
01/2013 - 02/2005
6Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2012 - 02/2004
5Hematologic Neoplasms (Hematological Malignancy)
12/2013 - 06/2004
4Bronchiolitis Obliterans Syndrome
08/2013 - 04/2005
4Mycoses (Diseases, Fungus)
05/2011 - 05/2005
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
07/2008 - 05/2005
3Pneumonia (Pneumonitis)
12/2013 - 04/2005
3Neoplasms (Cancer)
12/2013 - 06/2005
3Fever (Fevers)
03/2012 - 08/2009
2Aplastic Anemia (Anemia, Hypoplastic)
07/2013 - 11/2005
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2012 - 05/2005
2Philadelphia Chromosome
06/2012 - 06/2005
2Hemorrhagic Cystitis
09/2008 - 10/2007
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/2006 - 05/2005
1Pathologic Complete Response
12/2013
1Epstein-Barr Virus Infections
08/2013
1Residual Neoplasm
08/2013
1Invasive Fungal Infections
03/2013
1Hypoxia (Hypoxemia)
03/2013
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
02/2013
1Hyponatremia
01/2013
1Seizures (Absence Seizure)
01/2013
1Hereditary Spherocytosis
03/2012
1Agranulocytosis (Granulocytopenia)
08/2011
1Nephrotic Syndrome (Syndrome, Nephrotic)
07/2011
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
11/2010
1Chemical and Drug Induced Liver Injury
05/2010
1Aspergillosis
02/2010
1Reinfection
10/2009
1Diarrhea
08/2009
1Mucositis
08/2009
1Thrombocytopenia (Thrombopenia)
04/2009
1Cytomegalovirus Infections (Inclusion Disease)
02/2009
1Viremia
12/2008
1Enteritis
07/2008
1Multiple Myeloma
03/2007
1Blast Crisis (Blast Phase)
08/2006
1Hepatic Encephalopathy
11/2005
1Liver Diseases (Liver Disease)
11/2005
1Liver Failure
11/2005
1beta-Thalassemia (Cooley's Anemia)
11/2005
1Pure Red-Cell Aplasia
09/2005
1Hemorrhagic Shock
05/2005
1Hemorrhage
05/2005
1Refractory Anemia
05/2005
1Peptic Ulcer (Peptic Ulcers)
05/2005
1Refractory Anemia with Excess of Blasts (RAEM)
05/2005

Drug/Important Bio-Agent (IBA)

5Cyclosporine (Ciclosporin)FDA LinkGeneric
07/2015 - 05/2005
5Methotrexate (Mexate)FDA LinkGeneric
07/2015 - 04/2005
4HLA Antigens (Human Leukocyte Antigens)IBA
11/2012 - 06/2004
3Mycophenolic Acid (Cellcept)FDA LinkGeneric
12/2013 - 05/2005
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2013 - 03/2007
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2013 - 06/2004
2Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
12/2013 - 07/2013
2Busulfan (Busulfex)FDA Link
12/2013 - 03/2007
2fludarabineIBA
12/2013 - 12/2013
2Imatinib Mesylate (Gleevec)FDA Link
06/2012 - 07/2008
2Monoclonal AntibodiesIBA
12/2010 - 11/2008
2Immunosuppressive Agents (Immunosuppressants)IBA
04/2009 - 11/2005
2Antiviral Agents (Antivirals)IBA
02/2009 - 05/2005
2DNA (Deoxyribonucleic Acid)IBA
02/2009 - 12/2008
2Itraconazole (Sporanox)FDA LinkGeneric
01/2007 - 06/2005
1Pharmaceutical PreparationsIBA
12/2013
1Cytarabine (Cytosar-U)FDA LinkGeneric
12/2013
1SemustineIBA
12/2013
1Adrenal Cortex Hormones (Corticosteroids)IBA
03/2013
1Oxygen (Dioxygen)IBA
03/2013
1Ceruloplasmin (Ferroxidase)IBA
01/2013
1Anti-Bacterial Agents (Antibiotics)IBA
05/2011
1GlucocorticoidsIBA
12/2010
1EnzymesIBA
05/2010
1galactomannanIBA
02/2010
1BilirubinIBA
08/2009
1Transaminases (Aminotransferases)IBA
08/2009
1ValganciclovirFDA Link
12/2008
1OF 900IBA
12/2008
1BasiliximabFDA Link
11/2008
1Messenger RNA (mRNA)IBA
08/2006
1N 30IBA
08/2006
1AcidsIBA
05/2005
1Omeprazole (Prilosec)FDA LinkGeneric
05/2005
1ABO Blood-Group SystemIBA
02/2005

Therapy/Procedure

41Hematopoietic Stem Cell Transplantation
07/2015 - 02/2004
11Transplantation
11/2013 - 06/2004
10Therapeutics
12/2013 - 04/2005
7Stem Cell Transplantation
10/2009 - 11/2005
3Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
07/2013 - 08/2004
1Aftercare (After-Treatment)
12/2010
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
05/2010
1Platelet Transfusion (Blood Platelet Transfusions)
08/2009
1Donor Selection
06/2005
1Intravenous Injections
06/2005
1Oral Administration
06/2005
1Intravenous Administration
06/2005
1Erythrocyte Transfusion
05/2005